Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons 
China Manufacturing PMI Slips Into Contraction in January as Weak Demand Pressures Economy 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions 
South Korea Exports Surge in January on AI Chip Demand, Marking Fastest Growth in 4.5 Years 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Asian Currencies Hold Firm as Dollar Rebounds on Fed Chair Nomination Hopes 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.
